Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioseal as Adjunct to Sutured Dural Repair
NCT03110783Phase 3Completed
- Sponsor
- Guangzhou Bioseal Biotech
- Start
- Sep 2017
- Primary completion
- Sep 2019
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of Bioseal in cerebrospinal fluid leak (2 arms), sponsored by Guangzhou Bioseal Biotech. Primary endpoint: Proportion of success (watertight closure) CSF leakage. Started Sep 2017; status: completed.
02
Drugs
Bioseal
03
Conditions
cerebrospinal fluid leak
Beyond the preview
Go deeper on NCT03110783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03110783.